Abstract
Purpose
The aim of this study was to determine the effect of hyperbilirubinemia in the sensitivity of percutaneous transluminal forceps biopsy (PTFB) in patients with suspected malignant biliary stricture.
Materials and Methods
Ninety-three patients with suspicion of malignant biliary stricture underwent percutaneous transhepatic cholangiography followed by PTFB. Sensitivity, specificity and predictive values were analysed based on the presence or absence of hyperbilirubinemia, defined as total bilirubin equal to, or higher than 5 mg/dL. Variables included demographic and clinical features, laboratory, tumour type and localization, stricture length, therapeutic approach and histopathology. Additionally, major morbidity and mortality were assessed.
Results
The overall sensitivity, specificity, positive predictive value and accuracy of PTFB were 61.1%, 100%, 100%, and 62.4%, respectively. Hyperbilirubinemia affected 57% of patients at the time of PTFB. There were 35 (37%) false negative results, none of them related to tumour type or localization, stricture length, or previous biliary intervention (i.e. PBBD (percutaneous biliary balloon dilatation), ERCP (endoscopic retrograde cholangiopancreatography)) (p > 0.05). However, when bilirubin was < 5 mg/dL, false negative results decreased globally (p = 0.024) and sensitivity increased significantly for intrahepatic and hilar localization, as well as for colorectal metastasis, gallbladder carcinoma, and pancreatic carcinoma. No major morbidity occurred.
Conclusion
The sensitivity of percutaneous transluminal biopsy for diagnosis of malignant stricture may significantly increase if samples are obtained in the absence of hyperbilirubinemia, without adding morbidity to the procedure.
Level of Evidence
Level 3, Case- Control studies.
Similar content being viewed by others
References
Sumiyoshi T, Shima Y, Okabayashi T, et al. Mucinous cholangiocarcinoma: Clinicopathological features of the rarest type of cholangiocarcinoma. Ann Gastroenterol Surg. 2017;1(2):114–21. https://doi.org/10.1002/ags3.12016.
Tibana TK, Grubert RM, Fornazari VAV, et al. The role of percutaneous transhepatic biliary biopsy in the diagnosis of patients with obstructive jaundice: An initial experience. Radiol Bras. 2019;52(4):222–8. https://doi.org/10.1590/0100-3984.2018.0073.
Mohkam K, Malik Y, Derosas C, et al. Percutaneous transhepatic cholangiographic endobiliary forceps biopsy versus endoscopic ultrasound fine needle aspiration for proximal biliary strictures: a single-centre experience. HPB. 2017;19(6):530–7. https://doi.org/10.1016/j.hpb.2017.02.001.
Du L, D’Souza P, Thiesen A, et al. Percutaneous transhepatic cholangioscopy for indeterminate biliary strictures using the SpyGlass system: A case series. Endoscopy. 2015;47(11):1054–6. https://doi.org/10.1055/s-0034-1392527.
Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol. 2008;14(26):4131–6. https://doi.org/10.3748/wjg.14.4131.
Tapping CR, Byass OR, Cast JEI. Cytological sampling versus forceps biopsy during percutaneous transhepatic biliary drainage and analysis of factors predicting success. Cardiovasc Intervent Radiol. 2012;35(4):883–9. https://doi.org/10.1007/s00270-011-0193-z.
Zayac A, Almhanna K. Hepatobiliary cancers and immunotherapy: Where are we now and where are we heading? Transl Gastroenterol Hepatol. 2020. https://doi.org/10.21037/TGH.2019.09.07.
Li Z, Li TF, Ren JZ, et al. Value of percutaneous transhepatic cholangiobiopsy for pathologic diagnosis of obstructive jaundice: Analysis of 826 cases. Acta radiol. 2017;58(1):3–9. https://doi.org/10.1177/0284185116632386.
Tamada K, Satoh Y, Tomiyama T, et al. Multiple bile duct biopsies using a sheath with a side port: Usefulness of intraductal sonography. Am J Roentgenol. 2001;176(3):797–2. https://doi.org/10.2214/ajr.176.3.1760797.
Clavien PA, Barkun J, De Oliveira ML, et al. The clavien-dindo classification of surgical complications: Five-year experience. Ann Surg. 2009;250(2):187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.
Patel P, Rangarajan B, Mangat K. Improved Accuracy of Percutaneous Biopsy Using “Cross and Push” Technique for Patients Suspected with Malignant Biliary Strictures. Cardiovasc Intervent Radiol. 2015;38(4):1005–10. https://doi.org/10.1007/s00270-014-0976-0.
Savadere SJ. Intraductal biliary biopsy: Comparison of three techniques. J Vasc Interv Radiol. 1996;7(5):743–50. https://doi.org/10.1016/s1051-0443(96)70843-6.
Fohlen A, Bazille C, Menahem B, et al. Transhepatic forceps biopsy combined with biliary drainage in obstructive jaundice: safety and accuracy. Eur Radiol. 2019;29(5):2426–35. https://doi.org/10.1007/s00330-018-5852-x.
Garofalo AM, Lorente-Ros M, Goncalvez G, et al. Histopathological changes of organ dysfunction in sepsis. Intensive Care Med Exp. 2019;7(S1):1–5. https://doi.org/10.1186/s40635-019-0236-3.
Hucl T. (2019) Review article precursors to cholangiocarcinoma. Gastroenterol Res Pract.
Pinzani M, Luong TV. Pathogenesis of biliary fibrosis. Biochim Biophys Acta - Mol Basis Dis. 2018;1864(4):1279–83. https://doi.org/10.1016/j.bbadis.2017.07.026.
Shen N, Zhang D, Yin L, et al. Bile cell-free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer. Oncol Rep. 2019;42(2):549–50. https://doi.org/10.3892/or.2019.7177.
Wang D, He S, Chu L, Chao Q, Zhang Q, Shu H. A metastatic skull tumor from intrahepatic cholangiocarcinoma: A case report and literature review. Med (United States). 2019;98(49):1–5. https://doi.org/10.1097/MD.0000000000018291.
Perez-Johnston R, Deipolyi AR, Covey AM. Percutaneous Biliary Interventions. Gastroenterol Clin North Am. 2018;47(3):621–31. https://doi.org/10.1016/j.gtc.2018.04.008.
Elyaderani MK, Gabriele OF. Brush and forceps biopsy of biliary ducts via percutaneous transhepatic catheterization. Radiology. 1980;135(3):777–8. https://doi.org/10.1148/radiology.135.3.7384474.
Nunes TF, Tibana TK, Santos RFT, de Faria BB, Marchiori E. Percutaneous transhepatic cholangiobiopsy. Radiol Bras. 2019;52(1):41–2. https://doi.org/10.1590/0100-3984.2017.0228.
Inchingolo R, Spiliopoulos S, Nestola M, Nardella M. Outcomes of percutaneous transluminal biopsy of biliary lesions using a dedicated forceps system. Acta radiol. 2019;60(5):602–7. https://doi.org/10.1177/0284185118795319.
Zhang Y, Lu Y, Ji H, Li Y. Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury. Biosci Trends. 2019;13(1):23–31. https://doi.org/10.5582/bst.2018.01247.
Li TF, Ren KW, Han XW, et al. Percutaneous transhepatic cholangiobiopsy to determine the pathological cause of anastomotic stenosis after cholangiojejunostomy for malignant obstructive jaundice. Clin Radiol. 2014;69(1):13–7. https://doi.org/10.1016/j.crad.2013.05.096.
Jung GS, Do HuhJ, Lee SU, Han BH, Chang HK, Cho YD. Bile duct: Analysis of percutaneous transluminal forceps biopsy in 130 patients suspected of having malignant biliary obstruction. Radiology. 2002;224(3):725–30. https://doi.org/10.1148/radiol.2242011501.
Park JG, Jung GS, Yun JH, et al. Percutaneous transluminal forceps biopsy in patients suspected of having malignant biliary obstruction: factors influencing the outcomes of 271 patients. Eur Radiol. 2017;27(10):4291–7. https://doi.org/10.1007/s00330-017-4796-x.
Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93–102. https://doi.org/10.5114/ceh.2019.85166.
Funding
This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. The study was accepted by a local institutional review board.
Informed Consent
Informed consents were obtained before any procedure and the institutional review board at our institution authorized this study.
Consent for Publication
For this type of study consent for publication is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Oggero, A.S., Di Rocco, F., Huespe, P.E. et al. Impact of Cholestasis on the Sensitivity of Percutaneous Transluminal Forceps Biopsy in 93 Patients with Suspected Malignant Biliary Stricture. Cardiovasc Intervent Radiol 44, 1618–1624 (2021). https://doi.org/10.1007/s00270-021-02845-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-021-02845-x